Transcriptome Analysis of Human Glioblastoma Cells Susceptible to Infection with the Leningrad-16 Vaccine Strain of Measles Virus
Glioblastoma multiforme (GBM) accounts for almost half of all primary malignant brain tumors in adults and has a poor prognosis. Here we demonstrated the oncolytic potential of the L-16 vaccine strain of measles virus (MV) against primary human GBM cells and characterized the genetic patterns that d...
| Published in: | Viruses |
|---|---|
| Main Authors: | Yulia Ammour, Olga Susova, George Krasnov, Eugenia Nikolaeva, Vyacheslav Varachev, Yulia Schetinina, Marina Gavrilova, Alexey Mitrofanov, Anna Poletaeva, Ali Bekyashev, Evgeny Faizuloev, Vitaly V. Zverev, Oxana A. Svitich, Tatiana V. Nasedkina |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/14/11/2433 |
Similar Items
Measles Virus as a Vector Platform for Glioblastoma Immunotherapy (Review)
by: E. Yu. Nikolaeva, et al.
Published: (2022-02-01)
by: E. Yu. Nikolaeva, et al.
Published: (2022-02-01)
Human Melanoma and Glioblastoma Cells Express Cathepsins Supporting Reovirus Moscow Strain Infection
by: Yulia Ammour, et al.
Published: (2024-12-01)
by: Yulia Ammour, et al.
Published: (2024-12-01)
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference
by: Sophie C. Anker, et al.
Published: (2023-01-01)
by: Sophie C. Anker, et al.
Published: (2023-01-01)
A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
by: Daniel Loewe, et al.
Published: (2022-01-01)
by: Daniel Loewe, et al.
Published: (2022-01-01)
Zika Virus: A Neurotropic Warrior against High-Grade Gliomas—Unveiling Its Potential for Oncolytic Virotherapy
by: María-Angélica Calderón-Peláez, et al.
Published: (2024-04-01)
by: María-Angélica Calderón-Peláez, et al.
Published: (2024-04-01)
Dual Promoters Improve the Rescue of Recombinant Measles Virus in Human Cells
by: Soroth Chey, et al.
Published: (2021-08-01)
by: Soroth Chey, et al.
Published: (2021-08-01)
Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells
by: Ching-Hsuan Liu, et al.
Published: (2023-05-01)
by: Ching-Hsuan Liu, et al.
Published: (2023-05-01)
Measles Epidemics Among Children in Vietnam: Genomic Characterization of Virus Responsible for Measles Outbreak in Ho Chi Minh City, 2014
by: Van H. Pham, et al.
Published: (2014-12-01)
by: Van H. Pham, et al.
Published: (2014-12-01)
Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment
by: Camille Chatelain, et al.
Published: (2024-12-01)
by: Camille Chatelain, et al.
Published: (2024-12-01)
Level of measles herd immunity assessed in hospital medical workers within a framework of the state measles elimination program
by: M. P. Kostinov, et al.
Published: (2020-04-01)
by: M. P. Kostinov, et al.
Published: (2020-04-01)
Molecular genetic analysis of the strain Leningrad-16 used for the production of measles vaccine
by: Georgy M. Ignatyev, et al.
Published: (2020-05-01)
by: Georgy M. Ignatyev, et al.
Published: (2020-05-01)
Contagion comeback: unravelling the measles outbreak across the USA
by: Iman Muhammad Tahir, et al.
Published: (2024-12-01)
by: Iman Muhammad Tahir, et al.
Published: (2024-12-01)
Measles virus hemagglutinin: structural insights into cell entry and measles vaccine
by: Takao eHashiguchi, et al.
Published: (2011-12-01)
by: Takao eHashiguchi, et al.
Published: (2011-12-01)
Detection of measles vaccine virus and measles-specific immunoglobulin M in children vaccinated against measles-mumps-rubella during measles outbreak
by: Euri Seo, et al.
Published: (2024-06-01)
by: Euri Seo, et al.
Published: (2024-06-01)
Measles situation in Serbia in an era of measles elimination (2007-2009)
by: Nedeljković Jasminka, et al.
Published: (2013-01-01)
by: Nedeljković Jasminka, et al.
Published: (2013-01-01)
Equid Alphaherpesvirus 1 Modulates Actin Cytoskeleton and Inhibits Migration of Glioblastoma Multiforme Cell Line A172
by: Michalina Bartak, et al.
Published: (2022-03-01)
by: Michalina Bartak, et al.
Published: (2022-03-01)
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model
by: Jana Koch, et al.
Published: (2023-01-01)
by: Jana Koch, et al.
Published: (2023-01-01)
Molecular characterisation of the emerging measles virus from Roraima state, Brazil, 2018
by: Cátia Alexandra Ribeiro Meneses, et al.
Published: (2019-03-01)
by: Cátia Alexandra Ribeiro Meneses, et al.
Published: (2019-03-01)
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
by: Dubravko Forčić, et al.
Published: (2024-08-01)
by: Dubravko Forčić, et al.
Published: (2024-08-01)
Measles outbreak in the Children’s Hospital in Saint-Petersburg, 2012
by: M. A. Bichurina, et al.
Published: (2014-09-01)
by: M. A. Bichurina, et al.
Published: (2014-09-01)
Spatiotemporal Distribution and Genetic Characterization of Measles Strains Circulating in Greece during the 2017–2018 Outbreak
by: Vasiliki Pogka, et al.
Published: (2020-10-01)
by: Vasiliki Pogka, et al.
Published: (2020-10-01)
Characterization of Vaccine Breakthrough Cases during Measles Outbreaks in Milan and Surrounding Areas, Italy, 2017–2021
by: Silvia Bianchi, et al.
Published: (2022-05-01)
by: Silvia Bianchi, et al.
Published: (2022-05-01)
New Measles Genotype, Uganda
by: Apollo Muwonge, et al.
Published: (2005-10-01)
by: Apollo Muwonge, et al.
Published: (2005-10-01)
A REVIEW OF MEASLES VIRUS
by: Ivona Danova
Published: (2021-08-01)
by: Ivona Danova
Published: (2021-08-01)
Neutralizing Antibody Response to Genotypically Diverse Measles Viruses in Clinically Suspected Measles Cases
by: Sunil R. Vaidya, et al.
Published: (2023-11-01)
by: Sunil R. Vaidya, et al.
Published: (2023-11-01)
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
by: Karam Khaddour, et al.
Published: (2020-11-01)
by: Karam Khaddour, et al.
Published: (2020-11-01)
Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine
by: SHEN Jinhua, et al.
Published: (2022-05-01)
by: SHEN Jinhua, et al.
Published: (2022-05-01)
Tracking the 2024 measles outbreak: updates from Iraq
by: Alyaa Ali, et al.
Published: (2024-04-01)
by: Alyaa Ali, et al.
Published: (2024-04-01)
Molecular epidemiology of measles virus in Italy during 2008
by: Fabio Magurano, et al.
Published: (2013-03-01)
by: Fabio Magurano, et al.
Published: (2013-03-01)
Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds
by: Katharina S. Schmitz, et al.
Published: (2022-05-01)
by: Katharina S. Schmitz, et al.
Published: (2022-05-01)
A Serological Survey of Measles and Rubella Antibodies among Different Age Groups in Eastern China
by: Rui Yan, et al.
Published: (2024-07-01)
by: Rui Yan, et al.
Published: (2024-07-01)
Comparison of measles incidence in different age groups with the intensity of specific humoral immunity in healthcare workers in Moscow
by: M. P. Kostinov, et al.
Published: (2022-03-01)
by: M. P. Kostinov, et al.
Published: (2022-03-01)
COVID-19: Measles and Antibiotic Resistance Are a Matter of Concern
by: Giovanni Di Guardo
Published: (2021-04-01)
by: Giovanni Di Guardo
Published: (2021-04-01)
Ongoing Measles Outbreak in Orthodox Jewish Community, London, UK
by: Vanessa Baugh, et al.
Published: (2013-10-01)
by: Vanessa Baugh, et al.
Published: (2013-10-01)
Viral Oncolysis — Can Insights from Measles Be Transferred to Canine Distemper Virus?
by: Stefanie Lapp, et al.
Published: (2014-06-01)
by: Stefanie Lapp, et al.
Published: (2014-06-01)
Laboratory response to an infant with suspected measles vaccine associated fever and rash in Sri Lanka
by: Buddhini Samaraweera, et al.
Published: (2023-03-01)
by: Buddhini Samaraweera, et al.
Published: (2023-03-01)
Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy
by: Gabriele Anichini, et al.
Published: (2020-02-01)
by: Gabriele Anichini, et al.
Published: (2020-02-01)
Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach
by: Naseer F, et al.
Published: (2023-01-01)
by: Naseer F, et al.
Published: (2023-01-01)
Measles Outbreak in Lambu Internally Displaced Persons´ Camp, Maiduguri, Borno State, Nigeria, 2017
by: Taiwo Israel Olasoju, et al.
Published: (2024-06-01)
by: Taiwo Israel Olasoju, et al.
Published: (2024-06-01)
Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction]
by: Naseer F, et al.
Published: (2024-06-01)
by: Naseer F, et al.
Published: (2024-06-01)
Similar Items
-
Measles Virus as a Vector Platform for Glioblastoma Immunotherapy (Review)
by: E. Yu. Nikolaeva, et al.
Published: (2022-02-01) -
Human Melanoma and Glioblastoma Cells Express Cathepsins Supporting Reovirus Moscow Strain Infection
by: Yulia Ammour, et al.
Published: (2024-12-01) -
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference
by: Sophie C. Anker, et al.
Published: (2023-01-01) -
A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
by: Daniel Loewe, et al.
Published: (2022-01-01) -
Zika Virus: A Neurotropic Warrior against High-Grade Gliomas—Unveiling Its Potential for Oncolytic Virotherapy
by: María-Angélica Calderón-Peláez, et al.
Published: (2024-04-01)
